Your browser doesn't support javascript.
loading
The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women.
Spurdle, A B; Hopper, J L; Chen, X; Dite, G S; McCredie, M R; Giles, G G; Venter, D J; Southey, M C; Purdie, D M; Chenevix-Trench, G.
Affiliation
  • Spurdle AB; Oncology Division, Joint Experimental Oncology Programme, The Queensland Institute of Medical Research, and The University of Queensland, Brisbane, QLD 4029 Australia.
Cancer Epidemiol Biomarkers Prev ; 10(12): 1287-93, 2001 Dec.
Article in En | MEDLINE | ID: mdl-11751447
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Polymorphism, Genetic / 3-Oxo-5-alpha-Steroid 4-Dehydrogenase / Breast Neoplasms / Genetic Predisposition to Disease Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Country/Region as subject: Oceania Language: En Journal: Cancer Epidemiol Biomarkers Prev Journal subject: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Year: 2001 Document type: Article Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Polymorphism, Genetic / 3-Oxo-5-alpha-Steroid 4-Dehydrogenase / Breast Neoplasms / Genetic Predisposition to Disease Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Country/Region as subject: Oceania Language: En Journal: Cancer Epidemiol Biomarkers Prev Journal subject: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Year: 2001 Document type: Article Country of publication: